Jones Financial Companies
AQST icon

Jones Financial Companies’s Aquestive Therapeutics AQST Stock Holding History

Jones Financial Companies’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Hold
4,150
– – ﹤0.01% 3548
2026
Q1 		$16.7K Sell
4,150
-30
-0.7% -$122 ﹤0.01% 3363
2025
Q4 		$27K Buy
4,180
+3,275
+362% +$20.4K ﹤0.01% 2810
2025
Q3 		$5.42K Buy
905
+675
+293% +$2.92K ﹤0.01% 3337
2025
Q2 		$748 Buy
230
+30
+15% +$86 ﹤0.01% 3723
2025
Q1 		$604 Buy
+200
New +$605 ﹤0.01% 3491

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Jones Financial Companies's AQST Position: Q2 2026 in Review

Jones Financial Companies held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 4,150 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3548.

Jones Financial Companies first reported a position in AQST in Q1 2025 and has held it in 6 quarters since. The position peaked at $27K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Jones Financial Companies held 4,150 shares of Aquestive Therapeutics worth $18.2K as of Q2 2026.
  • Jones Financial Companies left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3548 holding.
  • Jones Financial Companies first reported a position in Aquestive Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Jones Financial Companies's Aquestive Therapeutics position peaked at $27K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.